Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Centella asiatica + Sijunzi is a combination of two traditional herbal medicines. Centella asiatica, also known as gotu kola or Brahmi, is a medicinal plant widely used in traditional medicine for its neuroprotective, wound healing, anti-inflammatory, and antioxidant properties. Its main active constituents include asiaticoside, madecassoside, and asiatic acid. Sijunzi (Si Jun Zi Tang) is a classic Chinese herbal formula composed of four herbs (Ginseng Radix [Ren Shen], Atractylodis Macrocephalae Rhizoma [Bai Zhu], Poria [Fu Ling], and Glycyrrhizae Radix [Gan Cao]) traditionally used to tonify the spleen and improve digestive function. The combination may be used in integrative or traditional medicine settings for synergistic effects on neurological health or general vitality; however, robust clinical data on this specific combination are limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on centella asiatica + sijunzi.